Evaluation of 1H-Magnetic Resonance Spectroscopy of Breast Cancer Pre- and Postgadolinium Administration

Abstract
We sought to evaluate spectroscopic measurements in breast cancer and compare variability in choline peak parameters related to contrast administration versus that inherent to repeated measurements. Single-voxel, proton spectroscopy measurements were obtained before and after the administration of gadolinium on 15 patients with ≥1-cm breast cancers. The protocol was repeated on a separate day in 7 patients. Postcontrast spectra demonstrated a significant increase in choline peak linewidth (day 1: 15% ± 21%, P = 0.03; day 2: 19% ± 12%, P = 0.001) and decrease in choline peak area (day 1: 11% ± 9% (P P Contrast administration caused significant increases in choline peak linewidth and decreases in choline peak area in spectroscopic measurements of breast cancer.